Table A3:
CSHRa | 95% CI | p-Value | |
---|---|---|---|
Gender | |||
Female & non-pregnant | 1.000 | - | - |
Female & pregnant | 1.169 | (1.072, 1.274) | <0.001 |
Male | 1.108 | (1.042, 1.179) | 0.001 |
Ageb, per 10 years | 0.769 | (0.742, 0.797) | <0.001 |
CD4b, per 100 cell/μL | 0.981 | (0.960, 1.002) | 0.070 |
HIV status disclosed | 0.927 | (0.869, 0.990) | 0.023 |
Travel time to clinic >30′ | 1.038 | (0.987, 1.092) | 0.148 |
Level of care | |||
Secondary/Tertiary | 1.000 | - | - |
Primary | 1.067 | (0.979, 1.163) | 0.142 |
Cause-specific hazard ratio
At ART initiation